News

Anixa Biosciences advances CAR T-cell therapy for recurrent ovarian cancer, targeting FSHR with promising safety and efficacy ...
Researchers use targeted lipid nanoparticles loaded with mRNA to reprogram T cells to fight autoimmune diseases ...
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without ...
Aiming T-cell engagers at autoimmune diseases continues to be a red-hot deal-making target, as evidenced by Otsuka ...
In recent years, cancer treatment has taken a big leap forward with a new, advancement known as CAR T-cell therapy. This may ...
CAR-T cells, which are genetically programmed to specifically recognize and kill target cells, have altered the therapeutic ...
Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer ...
A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare ...
A new AI tool, AAnet, has discovered five distinct cell types within tumors, offering a deeper look into cancer's inner ...
Researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA directly to T cells. The approach ...
In this video, Paolo F. Caimi, MD, MBA, discusses research evaluating whether multi-virus specific T-cells could enhance ...